| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| June 21st, 2008 | 26 | No |
Popular Name: Hydrocortisone Hydrocortisone
(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione
11beta,17,21-trihydroxypregn-4-ene-3,20-dione
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxypregn-4-ene-3,20-dione
11beta,17alpha,21-Trihydroxyprogesterone
4-Pregnene-11beta,17alpha,21-triol-3,20-dione
50-23-7; Hydrocortisone base; Prestwick_265
ALPHADERM; C21H30O5.CH4N2O; CALMURID HC; HYDROCORTISONE; UREA; LS-178496
B48448A1-24BA-47CA-8D9E-43E5BC949386
C21H30O5.C17H18FN3O3.Cl.H2O; CIPRO HC; CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE; LS-178511
CHEBI:58221; CHEBI:14023; CHEBI:3893; CHEBI:24633
Cortisol;11beta,17alpha,21-Trihydroxyprogesterone
CPD000653523; HYDROCORTISONE; Hydrocortisone base; SAM002264617
CPD000653523; HYDROCORTISONE; SAM002264617
Cyclodextrin-encapsulated hydrocortisone
hidrocortisona; hydrocortisone; hydrocortisonum
HYDROCORTISONE AND ACETIC ACID
Hydrocortisone Sodium Phosphate
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 1.62 | 3.13 | -14.6 | 3 | 5 | 0 | 95 | 362.466 | 2 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| Molecular_Solubility | 3.07 | Bitter DB |
| ALOGPS_SOLUBILITY | 1.99e-01 g/l | DrugBank-approved |
| Mp [°C] | 212 - 217 | Acros Organics |
| Melting_Point | 213-215? | Alfa-Aesar |
| Melting_Point | 213-215° | Alfa-Aesar |
| UniProt Database Links | 3BHS2_HUMAN; 5BPOR_DIGLA; ACTHR_HUMAN; AIP_HUMAN; ALEX_HUMAN; CASA1_MACEU; CBG_HUMAN; COLI_BALBO; COLI_BALPH; COLI_BOVIN; COLI_CAVPO; COLI_HUMAN; COLI_LOXAF; COLI_MACNE; COLI_MOUSE; COLI_NEOVI; COLI_PIG; COLI_RABIT; COLI_RAT; COLI_SHEEP; COT2_BOVIN; COT2_ | ChEBI |
| purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
| Purity | 95% | Fluorochem |
| mechanism | ACTH secretion inhibitor | IBScreen Bioactives |
| biological_source | Adrenal cortical hormone | ZereneX Building Blocks |
| biological_use | Antiallergic | IBScreen Bioactives |
| mechanism | Calcium mobilizer | IBScreen Bioactives |
| Patent Database Links | EP1438962; EP1579865; EP1629845; EP1652526; EP1656939; EP1801098; EP1808176; EP1864668; EP1886695; EP1918285; EP1920773; EP1935420; EP1958635; GB2004742; US2003236298; US2005288338; US2006004049; US2006079506; US2007149577; US2007184076; US2007208035; US2 | ChEBI |
| mechanism | Glucocorticoid | IBScreen Bioactives |
| Target | Glucocorticoid Receptor | Selleck Chemicals |
| mechanism | Glucocorticoid | IBScreen Bioactives |
| mechanism | Gluconeogenesis promoter | IBScreen Bioactives |
| mechanism | Glycogen deposition inhibitor | IBScreen Bioactives |
| H phrase | H361f: Suspected of damaging fertility | Acros Organics |
| biological_use | Immunosuppressive | IBScreen Bioactives |
| PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : H-1113 | NIH Clinical Collection via PubChem |
| Target | Others | Selleck Chemicals |
| P phrase | P281: Use personal protective equipment as required | Acros Organics |
| mechanism | Phosphorus mobilizer | IBScreen Bioactives |
| R phrase | R62: Possible risk of impaired fertility. | Acros Organics |
| R phrase | R62: Possible risk of impaired fertility.; R63: Possible risk of harm to the unborn child. | Acros Organics |
| Reactome Database Links | REACT_10023; REACT_10037; REACT_10043 | ChEBI |
| S phrase | S36/37: Wear suitable protective clothing and gloves. | Acros Organics |
| PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: H-1113 | NIH Clinical Collection via PubChem |
| biological_use | Topical antiinflammatory agent | IBScreen Bioactives IBScreen Bioactives |
| Hazard | XN: Harmful | Acros Organics |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| GCR-2-E | Glucocorticoid Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 30 | 0.41 | Binding ≤ 10μM |
| Z50594-7-O | Mus Musculus (cluster #7 Of 9), Other | Other | 15 | 0.42 | Functional ≤ 10μM |
| Z80418-3-O | RAW264.7 (Monocytic-macrophage Leukemia Cells) (cluster #3 Of 9), Other | Other | 61 | 0.39 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| GCR_HUMAN | P04150 | Glucocorticoid Receptor, Human | 30 | 0.41 | Binding ≤ 1μM |
| GCR_HUMAN | P04150 | Glucocorticoid Receptor, Human | 30 | 0.41 | Binding ≤ 10μM |
| Z50594 | Z50594 | Mus Musculus | 10 | 0.43 | Functional ≤ 10μM |
| Z80418 | Z80418 | RAW264.7 (Monocytic-macrophage Leukemia Cells) | 61 | 0.39 | Functional ≤ 10μM |
| Description | Species |
|---|---|
| Endogenous sterols | |
| Glucocorticoid biosynthesis |
| Description | Species |
|---|---|
| BMAL1:CLOCK,NPAS2 activates circadian gene expression |
No pre-computed analogs available. Try a structural similarity search.